A wide range of cancer and viral infections upregulate GRP78 and hijack its functions at multiple locations, thus anti-GRP78 agents can be efficacious against cancer, COVID-19, and other human diseases that depend on stress induction of GRP78 for their pathological progression. This evidence concerns the gene HSPA5 and COVID-19.